Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Finland

Marie Skłodowska-Curie Action · Running

IMMUFELLOW Interdisciplinary and Intersectoral Research Fellowship Program for Future Leaders in Immunology

Coordinator
Turun Yliopisto, Finland
Runs
1 August 2025 to 31 July 2030
Status
Running
EU funding
€3.7m
Total cost
—
Partners
37 organisations in 16 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101217173

What the project is doing

In the project's own words, from its summary on CORDIS.

Interdisciplinary and Intersectoral Research Fellowship Program for Future Leaders in Immunology (IMMUFELLOW) is an innovative postdoctoral training initiative of the University of Turku (UTU) and Åbo Akademi University (ÅAU) in Turku, Finland. Immune-related diseases, such as infections, atherosclerosis, and cancer, are increasing in prevalence and pose major societal/economic challenges. IMMUFELLOW will cultivate experts and leaders in immunology who will drive research advancements to address unmet needs in preventing and treating immune-mediated diseases.

IMMUFELLOW will build on UTU’s/ÅAU’s excellence in leadership development, advanced education models, and beyond state-of-the-art immunological research ecosystem and infrastructure. With 22 experienced postdoctoral researchers (ERs) recruited for 36-month terms via a rigorous, merit-based selection process, this initiative prioritizes interdisciplinary and intersectoral research, aligning with the European Charter and Code.

Supported by the InFLAMES Flagship, IMMUFELLOW fills a critical void in postdoctoral training, offering a structured program integrating science, technology and entrepreneurship. IMMUFELLOW ensures comprehensive research excellence and training opportunities beyond academia, with the following key features:Support and Mentoring: Each ER benefits from a dedicated intersectoral mentoring team, access to exceptional training opportunities, and monthly seminars/networking events.

Sector-Wide Involvement: Beyond academia, fellows explore research, training, and development opportunities in corporate settings, with education on regulatory standards/good practices in diagnostics, drug development, and manufacturing. Entrepreneurial Skills: Equipping fellows with the skills and knowledge to thrive in diverse professional environments. IMMUFELLOW thus stands at the forefront of postdoctoral training, fostering the next generation of leaders in immunology and driving impactful research advancements.

Who is involved

OrganisationCityCountryRole
Turun YliopistoTurkuFinlandCoordinator
Medizinische Universitaet WienWienAustriaAssociatedpartner
Universiteit GentGentBelgiumAssociatedpartner
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eVMunchenGermanyAssociatedpartner
Kobenhavns UniversitetKobenhavnDenmarkAssociatedpartner
Tartu UlikoolTartuEstoniaAssociatedpartner
Asociacion Centro De Investigacion Cooperativa En Biociencias Cic BioguneDerio VizcayaSpainAssociatedpartner
Aurlide LtdTurkuFinlandAssociatedpartner
Brinter OyTurkuFinlandAssociatedpartner
Business Turku Oy ABTurkuFinlandAssociatedpartner
Bayer OyTurkuFinlandAssociatedpartner
Biovian OyTurkuFinlandAssociatedpartner
Euro-Bioimaging EricTurkuFinlandAssociatedpartner
Faron Pharmaceuticals OyTurkuFinlandAssociatedpartner
Finnadvance OyHelsinkiFinlandAssociatedpartner
Misvik Biology OyTurkuFinlandAssociatedpartner
Orion OyjEspooFinlandAssociatedpartner
Olo Health OyTurkuFinlandAssociatedpartner
Radiometer Turku OyTurkuFinlandAssociatedpartner
Roche OyEspooFinlandAssociatedpartner
Upm-Kymmene OyjHelsinkiFinlandAssociatedpartner
Uniogen OyTurkuFinlandAssociatedpartner
Universite D'aix MarseilleMarseilleFranceAssociatedpartner
The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near DublinDublinIrelandAssociatedpartner
Fondazione Toscana Life SciencesSienaItalyAssociatedpartner
Universita Degli Studi Di SienaSienaItalyAssociatedpartner
The University of OsakaOsakaJapanAssociatedpartner
Erasmus Universitair Medisch Centrum RotterdamRotterdamNetherlandsAssociatedpartner
Technische Universiteit EindhovenEindhovenNetherlandsAssociatedpartner
Fundacao Calouste GulbenkianLisboaPortugalAssociatedpartner
Fujirebio Diagnostics ABGoeteborgSwedenAssociatedpartner
Karolinska InstitutetStockholmSwedenAssociatedpartner
King's College LondonLondonUnited KingdomAssociatedpartner
The Queen's University of BelfastBelfastUnited KingdomAssociatedpartner
University College LondonLondonUnited KingdomAssociatedpartner
The Trustees of Boston UniversityBoston MaUnited StatesAssociatedpartner
Uga Research Foundation Inc Non Profit CorpAthensUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI